Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A
Prevalence of Brain Metastases Immediately before Prophylactic Cranial Irradiation in Limited Disease Small Cell Lung Cancer Patients with Complete Remission.
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Evaluation of Kras Gene Mutation and Copy Number in Thymic Carcinomas and Thymomas  Hidefumi Sasaki, MD, PhD, Motoki Yano, MD, PhD, Yoshitaka Fujii, MD,
Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer
An Unusual Presentation of Malignant Pleural Mesothelioma
Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer  Daniel Morgensztern, MD, Saiama.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Hepatoid Carcinoma of the Lung with Anaplastic Lymphoma Kinase Gene Rearrangement  Sean Khozin, MD, Mark J. Roth, MD, Arun Rajan, MD, Karen Smith, MD,
Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430  Thomas E.
Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B   Martin.
A Patient with Mediastinal Mature Teratoma Presenting with Paraneoplastic Limbic Encephalitis  Katsunobu Kawahara, MD, Michiyo Miyawaki, MD, Kentarou.
Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third- Line Chemotherapy for Small Cell Lung Cancer  Satoshi Igawa, MD, PhD,
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib  Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition  Sai-Hong.
Mecit Kantarci, MD, PhD, Fadime Fil, MD, Ummugulsum Bayraktutan, MD 
Massive Bronchogenic Cyst
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer  Tateaki Naito, MD, PhD, Fumihiro Tanaka, MD, PhD, Akira Ono, MD,
Do Complex Mutations of the Epidermal Growth Factor Receptor Gene Reflect Intratumoral Heterogeneity?  Akito Hata, MD, Shiro Fujita, MD, PhD, Reiko Kaji,
Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer  Gyo Asai, MD, PhD, Nobuyuki.
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Non–Small-Cell Lung Cancer with HER2 Exon 20 Mutation: Regression with Dual HER2 Inhibition and Anti-VEGF Combination Treatment  Gerald S. Falchook, MD,
PET/CT Findings for Bone Marrow Carcinosis Because of Lung Adenocarcinoma  Keisuke Watanabe, MD, Masaharu Shinkai, MD, PhD, Kenjiro Nagai, MD, Nobuhiro.
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma  Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,
Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients 
Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L
Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma
Mitotic Inhibitors Journal of Thoracic Oncology
An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers  Jules L. Derks, MD  Journal of.
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma  Naoyuki.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer  Allison Ackerman, MD, Michael A. Goldstein,
Jennifer S. Temel, MD, William F. Pirl, MD, Christopher J
Lymphovascular Invasion in Non–Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy  Kristin A Higgins, MD, Junzo P Chino, MD, Neal Ready,
Pulmonary Metastasectomy in Breast Cancer
Nicholas W. Choong, MD, Robert S. Hellman, MD 
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Docetaxel in Combination with Either Cisplatin or Gemcitabine in Unresectable Non- small Cell Lung Carcinoma: A Randomized Phase II Study by the Japan.
Giant Desmoid Tumor of the Chest Wall
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL?  Emmet E. McGrath, MB, PhD  Journal of Thoracic.
Extended Resections for Thymic Malignancies
Genetic Changes in Squamous Cell Lung Cancer: A Review
International Thymic Malignancies Interest Group: A Way Forward
European Lung Cancer Conference (ELCC) 2016 Organisation
S-1 Treatment for Chemorefractory Thymic Carcinoma
Collaterals Journal of Thoracic Oncology
Intrathoracic Desmoid Tumor: Brief Report and Review of Literature
David Garfield, MD  Journal of Thoracic Oncology 
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Robert Comis, MD, The Passing of a “Lung Man”
Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues”  Boris Sepesi,
Presentation transcript:

Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin Satoshi Igawa, MD, PhD, Haruyasu Murakami, MD, PhD, Nobuyuki Yamamoto, MD, PhD  Journal of Thoracic Oncology  Volume 4, Issue 6, Pages 778-779 (June 2009) DOI: 10.1097/JTO.0b013e3181a52e74 Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 A, Computed tomography before administration of AMR. B, Marked diminution in size of the mass in the anterior mediastinum. Journal of Thoracic Oncology 2009 4, 778-779DOI: (10.1097/JTO.0b013e3181a52e74) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Clinical course and serum levels of neuron specific enolase (NSE) and progastrin-releasing peptide (ProGRP). Journal of Thoracic Oncology 2009 4, 778-779DOI: (10.1097/JTO.0b013e3181a52e74) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.